| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $7.76B | +10.9% |
| Cost of Revenue | $4.66B | +13.6% |
| Gross Profit | $3.10B | +7.1% |
| R&D Expense | $440.9M | +4.4% |
| SG&A Expense | $1.77B | +5.2% |
| Interest Expense | $123.2M | +30.2% |
| Pre-tax Income | $1.07B | -29.7% |
| Income Tax | $154.5M | -15.1% |
| Net Income | $932.2M |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $490.7M | -25.9% |
| Short-term Investments | $12.6M | +2000.0% |
| Accounts Receivable | $1.74B | +21.9% |
| Inventory | $1.05B | +32.1% |
| Current Assets | $3.61B | +17.9% |
| Total Assets | $10.76B | +0.5% |
| Current Liabilities | $3.57B | +19.4% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $823.1M | -34.7% |
| Capital Expenditures | $141.1M | +17.3% |
| Investing Cash Flow | -$7.8M | +99.7% |
| Financing Cash Flow | -$934.2M | -172.0% |
| Free Cash Flow | $682.0M | -40.2% |
| -31.4% |
| EPS (Basic) | $8.02 | -31.4% |
| EPS (Diluted) | $7.97 | -31.2% |
| Long-term Debt |
| $2.87B |
| -17.2% |
| Stockholders' Equity | $2.73B | +14.1% |